Company / Tangible Book Value per Share
Repligen Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$17533.65
FY2025
5-year range
$15536.90 / $18365.45
FY2021-FY2025
Trend
+4.1%
vs FY2024
Sector context
#1 of 209
Health Care
What the data says
Among 209 Health Care companies, Repligen is in the top 0% for tangible book value per share. Tangible Book Value per Share returned to growth in FY2025 after 2 years of decline, reaching $17533.65.
Based on SEC 10-K filings.
17533.65 in FY2025 with a 5-year CAGR of +0.7%. Ranks 1st among 209 companies in Health Care.
Remained stable around $17533.65 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -1.5%
- 5-Year CAGR
- +0.7%
- 10-Year CAGR
- -
Sector benchmark
+14542.5% above sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 4.1% year-over-year.
- Ranks #1 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17533.65 | +4.1% |
| FY2024 | $16835.42 | -2.9% |
| FY2023 | $17342.62 | -5.6% |
| FY2022 | $18365.45 | +18.2% |
| FY2021 | $15536.90 | -8.1% |
| FY2020 | $16901.30 | +140533.9% |
| FY2019 | $12.02 | +89.2% |
| FY2018 | $6.35 | -18.6% |
| FY2017 | $7.81 | +135.5% |
| FY2016 | $3.31 | +20.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026